価格表

在庫・価格 : 2024年06月08日 01時01分 現在

商品名 商品コード メーカー 包装 価格 在庫 リスト
Osteopontin, Human, ELISA Kit, RayBio (1×96well)
データシート
ELH-OPN-1 RAYレイバイオテック
RayBiotech, Inc
1 kit ¥95,000
(未発注)
追加

在庫・価格 : 2024年06月08日 01時01分 現在

Osteopontin, Human, ELISA Kit, RayBio (1×96well)

  • 商品コード:ELH-OPN-1
  • メーカー:RAY
  • 包装:1kit
  • 価格: ¥95,000
  • 在庫:無(未発注)
使用文献
No. 文献情報 備考 参照
1 Von Neuhoff N, Oumeraci T, Wolf T, et al. Monitoring CSF Proteome Alterations in Amyotrophic Lateral Sclerosis: Obstacles and Perspectives in Translating a Novel Marker Panel to the Clinic. Borchelt DR, ed. PLoS ONE. 2012;7(9):e44401. doi:10.1371/journal.

Species: Human, Sample Type: CSF PubMed
2 Nagy E, Eriksson P, Yousry M, et al. Valvular osteoclasts in calcification and aortic valve stenosis severity. Int J Cardiol. 2013 Feb 27; [Epub ahead of print] doi:10.1016/j.ijcard.2013.01.207.

Species: Human, Sample Type: Plasma PubMed
3 Abdul Wahab Ali K., Abdulbari A., Hamdi R. Determination of Procollagen 1 N Terminal Peptide and Osteopontin in Postmenopausal Women with Vertebral Osteoporotic Fractures. KASR EL AINI MEDICAL JOURNAL VOL. 18, NO 3, July 2012

Species: Human, Sample Type: Serum PubMed
4 Gluba-Brzozka A., et al. Markers of increased cardiovascular risk in patients with chronic kidney disease. Lipids in Health and Disease 2014, 13:135 doi:10.1186/1476-511X-13-135

Species: Human, Sample Type: Serum PubMed
5 Hafez SS, El Sebai AA, Al Aziz MM, et al. Alfa-Fetoprotein L3 Subfraction and Osteopontin: Novel Markers for the Diagnosis of Hepatocellular Carcinoma. J Am Sci. 2013;9(3).

Species: Human, Sample Type: Serum PubMed
6 Bassyouni IH et al. Soluble levels of osteopontin in patients with Behcet"s disease: association with disease activity and vascular involvement. J. Clin. Immunol. 2013 Feb;33(2):361-7
Bassyouni IH et al
2013/01/01
Species: Human, Sample Type: Plasma PubMed
7 Taranta-Janusz K et al. Osteopontin and symmetric dimethylarginine plasma levels in solitary functioning kidney in children. Acta Paediatr. 2012 Aug;101(8):e369-72
Taranta-Janusz K et al
2012/01/01
Species: Human, Sample Type: Plasma PubMed
8 Von Neuhoff N, Oumeraci T, Wolf T, et al. Monitoring CSF Proteome Alterations in Amyotrophic Lateral Sclerosis: Obstacles and Perspectives in Translating a Novel Marker Panel to the Clinic. Borchelt DR, ed. PLoS ONE. 2012;7(9):e44401. doi:10.1371/journal.

PubMed
9 Nagy E, Eriksson P, Yousry M, et al. Valvular osteoclasts in calcification and aortic valve stenosis severity. Int J Cardiol. 2013 Feb 27; [Epub ahead of print] doi:10.1016/j.ijcard.2013.01.207.

PubMed
10 Filis K., Martinakis V., Galyfos G., Sigala F., Theodorou D., Andreadou I., Zografos G. OSTEOPONTIN AND OSTEOPROTEGERIN AS POTENTIAL BIOMARKERS IN ABDOMINAL AORTIC ANEURYSM BEFORE AND AFTER TREATMENT. International Scholarly Research Notices, 2014 May, Ep

PubMed
11 Bassyouni I., Bassyouni R., Ibrahim N., Soliman A. Elevated serum osteopontin levels in chronic hepatitis C virus infection: association with autoimmune rheumatologic manifestations. J Clin Immunol. 2012 Dec;32(6):1262-9. doi: 10.1007/s10875-012-9727-7.
Bassyouni IH et al
2012/01/01
PubMed
12 Wu T., Ding H., Han J., et al. Antibody-Array-Based Proteomic Screening of Serum Markers in Systemic Lupus Erythematosus: A Discovery Study. J Proteome Res. 2016 Jul 1;15(7):2102-14. doi: 10.1021/acs.jproteome.5b00905.
Wu T et al
2016/01/01
PubMed
13 Acar A., Cevik M., Arikanoglu A., et al. Serum levels of calcification inhibitors in patients with intracerebral hemorrhage. Int J Neurosci. 2012 May;122(5):227-32. doi: 10.3109/00207454.2011.642039.
Acar A et al
2012/01/01
PubMed
14 Hussein Y., Alhazmi A., Alzahrani S., et al. Osteopontin as a Marker for Response to Pegylated Interferon Alpha-2b Treatment in Chronic HCV Saudi Patients. Vol 21, No. 12;Dec 2014. 445 - 454

PubMed
15 Erturkler, Enis, et al. "Plasma osteopontin levels in patients with Behcet"s disease and psoriasis." European Journal of Dermatology 21.2 (2011): 203-208.
Erturkler E et al
PubMed
16 Shaker, Olfat, et al. "Osteopontin gene polymorphisms as predictors for the efficacy of interferon therapy in chronic hepatitis C Egyptian patients with genotype 4." Cell biochemistry and function 31.7 (2013): 620-625.
Shaker O et al
2013/01/01
PubMed
17 Hydzik P et al. [Osteopontin level in the serum of patients with alcoholic liver disease, treated for alcohol withdrawal syndrome--a preliminary report]. Przegl Lek 2013;70(8):542-5
Hydzik P et al
2013/01/01
PubMed
  • No.: 1
  • 文献情報:
    Von Neuhoff N, Oumeraci T, Wolf T, et al. Monitoring CSF Proteome Alterations in Amyotrophic Lateral Sclerosis: Obstacles and Perspectives in Translating a Novel Marker Panel to the Clinic. Borchelt DR, ed. PLoS ONE. 2012;7(9):e44401. doi:10.1371/journal.

  • 備考:
    Species: Human, Sample Type: CSF
  • 参照:
    PubMed
  • No.: 2
  • 文献情報:
    Nagy E, Eriksson P, Yousry M, et al. Valvular osteoclasts in calcification and aortic valve stenosis severity. Int J Cardiol. 2013 Feb 27; [Epub ahead of print] doi:10.1016/j.ijcard.2013.01.207.

  • 備考:
    Species: Human, Sample Type: Plasma
  • 参照:
    PubMed
  • No.: 3
  • 文献情報:
    Abdul Wahab Ali K., Abdulbari A., Hamdi R. Determination of Procollagen 1 N Terminal Peptide and Osteopontin in Postmenopausal Women with Vertebral Osteoporotic Fractures. KASR EL AINI MEDICAL JOURNAL VOL. 18, NO 3, July 2012

  • 備考:
    Species: Human, Sample Type: Serum
  • 参照:
    PubMed
  • No.: 4
  • 文献情報:
    Gluba-Brzozka A., et al. Markers of increased cardiovascular risk in patients with chronic kidney disease. Lipids in Health and Disease 2014, 13:135 doi:10.1186/1476-511X-13-135

  • 備考:
    Species: Human, Sample Type: Serum
  • 参照:
    PubMed
  • No.: 5
  • 文献情報:
    Hafez SS, El Sebai AA, Al Aziz MM, et al. Alfa-Fetoprotein L3 Subfraction and Osteopontin: Novel Markers for the Diagnosis of Hepatocellular Carcinoma. J Am Sci. 2013;9(3).

  • 備考:
    Species: Human, Sample Type: Serum
  • 参照:
    PubMed
  • No.: 6
  • 文献情報:
    Bassyouni IH et al. Soluble levels of osteopontin in patients with Behcet"s disease: association with disease activity and vascular involvement. J. Clin. Immunol. 2013 Feb;33(2):361-7
    Bassyouni IH et al
    2013/01/01
  • 備考:
    Species: Human, Sample Type: Plasma
  • 参照:
    PubMed
  • No.: 7
  • 文献情報:
    Taranta-Janusz K et al. Osteopontin and symmetric dimethylarginine plasma levels in solitary functioning kidney in children. Acta Paediatr. 2012 Aug;101(8):e369-72
    Taranta-Janusz K et al
    2012/01/01
  • 備考:
    Species: Human, Sample Type: Plasma
  • 参照:
    PubMed
  • No.: 8
  • 文献情報:
    Von Neuhoff N, Oumeraci T, Wolf T, et al. Monitoring CSF Proteome Alterations in Amyotrophic Lateral Sclerosis: Obstacles and Perspectives in Translating a Novel Marker Panel to the Clinic. Borchelt DR, ed. PLoS ONE. 2012;7(9):e44401. doi:10.1371/journal.

  • 備考:
  • 参照:
    PubMed
  • No.: 9
  • 文献情報:
    Nagy E, Eriksson P, Yousry M, et al. Valvular osteoclasts in calcification and aortic valve stenosis severity. Int J Cardiol. 2013 Feb 27; [Epub ahead of print] doi:10.1016/j.ijcard.2013.01.207.

  • 備考:
  • 参照:
    PubMed
  • No.: 10
  • 文献情報:
    Filis K., Martinakis V., Galyfos G., Sigala F., Theodorou D., Andreadou I., Zografos G. OSTEOPONTIN AND OSTEOPROTEGERIN AS POTENTIAL BIOMARKERS IN ABDOMINAL AORTIC ANEURYSM BEFORE AND AFTER TREATMENT. International Scholarly Research Notices, 2014 May, Ep

  • 備考:
  • 参照:
    PubMed
  • No.: 11
  • 文献情報:
    Bassyouni I., Bassyouni R., Ibrahim N., Soliman A. Elevated serum osteopontin levels in chronic hepatitis C virus infection: association with autoimmune rheumatologic manifestations. J Clin Immunol. 2012 Dec;32(6):1262-9. doi: 10.1007/s10875-012-9727-7.
    Bassyouni IH et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 12
  • 文献情報:
    Wu T., Ding H., Han J., et al. Antibody-Array-Based Proteomic Screening of Serum Markers in Systemic Lupus Erythematosus: A Discovery Study. J Proteome Res. 2016 Jul 1;15(7):2102-14. doi: 10.1021/acs.jproteome.5b00905.
    Wu T et al
    2016/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 13
  • 文献情報:
    Acar A., Cevik M., Arikanoglu A., et al. Serum levels of calcification inhibitors in patients with intracerebral hemorrhage. Int J Neurosci. 2012 May;122(5):227-32. doi: 10.3109/00207454.2011.642039.
    Acar A et al
    2012/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 14
  • 文献情報:
    Hussein Y., Alhazmi A., Alzahrani S., et al. Osteopontin as a Marker for Response to Pegylated Interferon Alpha-2b Treatment in Chronic HCV Saudi Patients. Vol 21, No. 12;Dec 2014. 445 - 454

  • 備考:
  • 参照:
    PubMed
  • No.: 15
  • 文献情報:
    Erturkler, Enis, et al. "Plasma osteopontin levels in patients with Behcet"s disease and psoriasis." European Journal of Dermatology 21.2 (2011): 203-208.
    Erturkler E et al
  • 備考:
  • 参照:
    PubMed
  • No.: 16
  • 文献情報:
    Shaker, Olfat, et al. "Osteopontin gene polymorphisms as predictors for the efficacy of interferon therapy in chronic hepatitis C Egyptian patients with genotype 4." Cell biochemistry and function 31.7 (2013): 620-625.
    Shaker O et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed
  • No.: 17
  • 文献情報:
    Hydzik P et al. [Osteopontin level in the serum of patients with alcoholic liver disease, treated for alcohol withdrawal syndrome--a preliminary report]. Przegl Lek 2013;70(8):542-5
    Hydzik P et al
    2013/01/01
  • 備考:
  • 参照:
    PubMed